Dykema Gossett

Holley Ordered to Disgorge $2 Million in Ill-Gotten Profits

Retrieved on: 
Tuesday, April 9, 2024
Legal, Aftermarket, Automotive, Finance, General Automotive, Banking, Professional Services, Recreational Vehicles, Performance & Special Interest, Off-Road Trucks & SUVs, Warren, Michigan, District court, Vexatious litigation, Dykema Gossett, Motion, Judgement, Holley Performance Products, Settlement, Court, HP

“Proform”) that started 24 years ago when Holley filed suit against Specialty, alleging that Specialty had misappropriated the “trade dress” of Holley’s carburetor main bodies.

Key Points: 
  • “Proform”) that started 24 years ago when Holley filed suit against Specialty, alleging that Specialty had misappropriated the “trade dress” of Holley’s carburetor main bodies.
  • So in 2012 Specialty filed a summary enforcement motion suit claiming that Holley was failing to comply with the Settlement Agreement.
  • In 2017 Specialty filed its breach of contract lawsuit against Holley for violating the Settlement Agreement, arguing that it was entitled to disgorgement of the $2,028,264.19 in net profit reaped by Holley.
  • Specialty prevailed in this lawsuit, and the court entered summary judgment in favor of Specialty and against Holley.

AAM Names Aleksandra A. Miziolek to Board of Directors

Retrieved on: 
Wednesday, March 20, 2024
AXL, Retirement, General counsel, American Axle, Dykema Gossett, Senior, AAM, Corporation, Management

DETROIT, March 20, 2024 /PRNewswire/ -- American Axle & Manufacturing (NYSE: AXL) has named Aleksandra A. Miziolek to its Board of Directors.

Key Points: 
  • DETROIT, March 20, 2024 /PRNewswire/ -- American Axle & Manufacturing (NYSE: AXL) has named Aleksandra A. Miziolek to its Board of Directors.
  • Aleksandra is the Retired Chief Transformational Officer, Cooper-Standard Holdings, Inc.
    "Aleks brings significant industry and executive experience to the AAM board, with a valuable perspective on international and strategic matters," said David C. Dauch, Chairman and CEO, AAM.
  • Miziolek is an experienced public company director and most recently served as the Senior Vice President, Chief Transformation Officer for Cooper-Standard Holdings, Inc. until she retired in 2019.
  • Prior to joining Cooper-Standard, Miziolek was a Member, Director of the Automotive Industry Group for Dykema Gossett PLLC.

Jet.AI to Ring the Nasdaq Opening Bell on Friday, August 11, 2023, at 9:30 AM EST

Retrieved on: 
Thursday, August 10, 2023
Oxbridge, Dykema Gossett, Jet, Artificial intelligence, Social media, Cryptocurrency

He will be accompanied by the Company’s senior management team and Board of Directors.

Key Points: 
  • He will be accompanied by the Company’s senior management team and Board of Directors.
  • “We are honored to ring the Nasdaq opening bell on August 11th as we deliver on our commitment to create value for the company’s 32,000 shareholders,” said Mike Winston.
  • “I’d like to express my sincere gratitude to our shareholders, employees, customers, and partners on this extraordinary day.”
    The opening bell ceremony will be broadcasted live from the Nasdaq MarketSite Tower in New York City, New York at 9:30 AM Eastern Time.
  • Videos and photos during and following the ceremony will be shared on Nasdaq’s social media channels on: Facebook, Instagram, and Twitter.

Jet Token, Inc. & Oxbridge Acquisition Corp. Announce Filing of Registration Statement on Form S-4 in Connection with their Proposed Business Combination

Retrieved on: 
Tuesday, April 11, 2023
Dykema Gossett, King Edward Street, London, SEC filing, Person, Register, Suite, Acquisition, Jet, Form, Security (finance), Registration statement, Oxbridge

While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Jet and Oxbridge, as well as the proposed business combination transaction.

Key Points: 
  • While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Jet and Oxbridge, as well as the proposed business combination transaction.
  • Additionally, Oxbridge intends to file other documents regarding the proposed business combination transaction with the SEC in the future.
  • 333-270848), or by directing a request to Oxbridge Acquisition Corp., Suite 201, 42 Edward Street, George Town, Cayman Islands, KY1-9006.
  • Fox Rothschild LLP is serving as legal counsel for Jet and Dykema Gossett PLLC is serving as legal counsel for Oxbridge.

Jet Token Inc. to Become Publicly Listed via Business Combination with Oxbridge Acquisition Corp. and Change Name to Jet.AI Inc.

Retrieved on: 
Monday, February 27, 2023
Dykema Gossett, Intelligence, Prospectus, Form, LLP, Acquisition, Earnout, Growth, AI, Madhu, Black–Scholes model, Jet, LAS, Cryptocurrency, Oxbridge

The proposed business combination is expected to be completed late in the second quarter of 2023.

Key Points: 
  • The proposed business combination is expected to be completed late in the second quarter of 2023.
  • LAS VEGAS, NEVADA and GEORGETOWN, CAYMAN ISLANDS, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Jet Token Inc. (“Jet Token” or the “Company”), a private aviation booking and membership platform, and Oxbridge Acquisition Corp. (NASDAQ: OXAC)(“Oxbridge”), a publicly-traded special purpose acquisition company (“SPAC”), today announced they have entered into a definitive business combination agreement that is expected to result in Jet Token becoming publicly listed.
  • As such, Jet Token shareholders are expected to receive total mixed consideration of $105 million, or $0.72/per Jet Token share.
  • Fox Rothschild LLP is serving as legal counsel for Jet Token, and Dykema Gossett PLLC is serving as legal counsel for Oxbridge.

Ocean Biomedical to Ring The Nasdaq Stock Market Opening Bell

Retrieved on: 
Thursday, February 16, 2023
Benchmark, Times Square, RI, LLP, University, Biomedicine, Cancer, Nelson Mullins Riley & Scarborough, Pulmonary fibrosis, Patient, Research, Nasdaq MarketSite, Ocean Biomedical, EF Hutton, Infection, Dykema Gossett, Management, Pharmaceutical industry, Malaria

Providence, RI and New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“the Company”), (NASDAQ: OCEA) a next-generation biopharma company, today announced it will visit the Nasdaq MarketSite in Times Square to ring the Opening Bell on Thursday, February 16, 2023, from 9:15 a.m. to 9:30 a.m. ET. Leading the iconic ceremony will be Dr. Chirinjeev Kathuria, Ocean Biomedical co-founder and Executive Chairman of the Board of Directors. The company’s common stock and warrants are listed on Nasdaq under the symbols “OCEA” and “OCEAW,” respectively.

Key Points: 
  • Providence, RI and New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“the Company”), (NASDAQ: OCEA) a next-generation biopharma company, today announced it will visit the Nasdaq MarketSite in Times Square to ring the Opening Bell on Thursday, February 16, 2023, from 9:15 a.m. to 9:30 a.m.
  • Leading the iconic ceremony will be Dr. Chirinjeev Kathuria, Ocean Biomedical co-founder and Executive Chairman of the Board of Directors.
  • The company’s common stock and warrants are listed on Nasdaq under the symbols “OCEA” and “OCEAW,” respectively.
  • “Today is a landmark moment in the young life of Ocean Biomedical,” said Dr. Chirinjeev Kathuria, Ocean Biomedical co-founder and Executive Chairman of the Board of Directors.

Pinecrest Serves as Exclusive Financial Advisor to Cookies-n-Milk

Retrieved on: 
Tuesday, January 24, 2023
JTM, CNM, Security (finance), Partnership, Growth, Dykema Gossett, Family, Multimedia, Grocery store, TENEX

DALLAS, Jan. 24, 2023 /PRNewswire/ -- Pinecrest Capital Partners ("Pinecrest") is proud to announce that Cookies-n-Milk ("CnM"), a leading bakery and frozen dessert manufacturer based in McKinney, Texas, has been acquired by JTM Foods ("JTM"), a portfolio company of Tenex Capital Management ("Tenex"). Pinecrest served as the exclusive advisor to Cookies-n-Milk in this transaction.

Key Points: 
  • Pinecrest served as the exclusive advisor to Cookies-n-Milk in this transaction.
  • CnM's products are sold across the US through several channels, including convenience, grocery, food service, and fast casual restaurants nationwide.
  • Pinecrest Senior Managing Director Barrett Kingsriter, Director Wes Romanowski, and Senior Associate Austin Jolesch served as the investment bankers on the transaction.
  • "I was extremely impressed with the process that Pinecrest put together – I cannot thank them enough.

Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination

Retrieved on: 
Monday, February 6, 2023
Benchmark, Bangladesh Securities and Exchange Commission, Fibrosis, Security (finance), Malaria, Pulmonary fibrosis, Acquisition, LLP, Infection, Vaccine, Dykema Gossett, EF Hutton, Nelson Mullins Riley & Scarborough, Tuberculosis, CHI3L1, Brown University, Management, Pharmaceutical industry

NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company, today announced that its stockholders approved all proposals related to the previously announced proposed business combination between Aesther and Ocean at a special meeting of stockholders held on February 3, 2023.

Key Points: 
  • NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company, today announced that its stockholders approved all proposals related to the previously announced proposed business combination between Aesther and Ocean at a special meeting of stockholders held on February 3, 2023.
  • “The business combination with Aesther brings us one step closer to realizing our foremost goals as an innovative life sciences company.”
    “The future is unquestionably bright for Ocean Biomedical,” said Suren Ajjarapu, Chairman and CEO of Aesther.
  • Various fibrotic diseases may be vulnerable to the effects of the OCF-203 pathway inhibitor Chitinase 1 (Chit1), also identified by Ocean.
  • Ocean and Aesther have partnered with some of the premier investment institutions in the health care space.

Ocean Biomedical Provides Corporate Update and Company Summary

Retrieved on: 
Tuesday, January 24, 2023
Benchmark, Disease, Infection, Hermansky–Pudlak syndrome, Pulmonary fibrosis, Scleroderma, Lung cancer, SPAC, Research, Brown University, Fibrosis, Malaria, Yale University, Technology transfer, Glioblastoma, Harvard University, Non-small-cell lung carcinoma, Business architecture, Biomedicine, Nelson Mullins Riley & Scarborough, Stanford University, Prevalence, NSCLC, NASH, HPS, Tuberculosis, Brain, CHI3L1, Alcoholic liver disease, Idiopathic pulmonary fibrosis, Human, Acquisition, Cancer, LLP, Risk, Dykema Gossett, RI, EF Hutton, GBM, Patient, Growth, Pharmaceutical industry, Vaccine

PROVIDENCE, RI and NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“Ocean”), a next-generation biopharma company, and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA), a publicly traded special purpose acquisition company (SPAC), shared today an update on key company activities. Built on Ocean Biomedical’s expertise in technology transfer, a unique business model was created to bridge the ‘bench-to-bedside’ gap and accelerate the commercialization of novel assets from leading research universities and medical centers. Ocean Biomedical is expected to become a publicly traded company on NASDAQ under the symbols “OCEA” and “OCEAW” following the expected closing of a Business Combination with Aesther Corporation.

Key Points: 
  • PROVIDENCE, RI and NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“Ocean”), a next-generation biopharma company, and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA), a publicly traded special purpose acquisition company (SPAC), shared today an update on key company activities.
  • Ocean Biomedical is expected to become a publicly traded company on NASDAQ under the symbols “OCEA” and “OCEAW” following the expected closing of a Business Combination with Aesther Corporation .
  • “The scientific and operational progress Ocean Biomedical has had to date, even without access to the public markets, is astounding – the company is at an inflection point, with multiple ways to win.
  • Each of these assets are progressing towards the next stage of their development pipelines,” said Dr. Chirinjeev Kathuria, Ocean Biomedical co-founder and Executive Chairman of the Board of Directors.

World Insurance Associates Acquires Future Insurance Group

Retrieved on: 
Friday, December 9, 2022
Broker, Entrepreneurship, WIA, Insurance, CFO, Sasa, Dykema Gossett, Transport, P&C, Retirement, Financial services, Risk management

Iselin, NJ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- World Insurance Associates LLC (World), a Top 50 Insurance Brokerage, announced today that it acquired Future Insurance Group of Schererville, IN on December 1, 2022.

Key Points: 
  • Iselin, NJ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- World Insurance Associates LLC (World), a Top 50 Insurance Brokerage, announced today that it acquired Future Insurance Group of Schererville, IN on December 1, 2022.
  • Future Insurance Group is a family-owned insurance agency.
  • “We believe in educating our customers about their insurance options, and then working together to select the best options for their needs,” says Sasa Milosevic, Founder and President, Future Insurance Group.
  • We understand the importance of ensuring that our clients’ businesses are properly and adequately protected, and we continually monitor their insurance needs,” says Dragan Milosevic, CFO, Future Insurance Group.